The Pharmacokinetic Profile and Bioavailability of Enteral N-Acetylcysteine in Intensive Care Unit
<i>Background and Objectives</i>: N-acetylcysteine (NAC) is a mucolytic agent used to prevent ventilator-associated pneumonia in intensive care units. This study aimed to evaluate the oral bioavailability of NAC in critically ill patients with pneumonia, isolated acute brain injury and a...
Enregistré dans:
Auteurs principaux: | Kersti Teder, Liivi Maddison, Hiie Soeorg, Andres Meos, Juri Karjagin |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fcbf4b7f10cc4fa5ba0745f2073af60d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Absorption of N-acetylcysteine in Healthy and <i>Mycoplasma gallisepticum</i>-Infected Chickens
par: Tsvetelina Petkova, et autres
Publié: (2021) -
Zein-alpha lipoic acid-loaded nanoparticles to enhance the oral bioavailability of dapoxetine: optimization and clinical pharmacokinetic evaluation
par: El-Say KM, et autres
Publié: (2019) -
N-Acetylcysteine to Combat COVID-19: An Evidence Review
par: Shi Z, et autres
Publié: (2020) -
Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers
par: Oh DA, et autres
Publié: (2017) -
Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats
par: Zakarial Ansar FH, et autres
Publié: (2020)